MYLI
ELV icon

Meiji Yasuda Life Insurance’s Elevance Health ELV Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,520
Closed -$1.83M – 255
2024
Q1 		$1.83M Buy
3,520
+701
+25% +$349K 0.04% 117
2023
Q4 		$1.33M Buy
2,819
+822
+41% +$380K 0.03% 150
2023
Q3 		$870K Sell
1,997
-149
-7% -$67.6K 0.02% 168
2023
Q2 		$953K Buy
2,146
+271
+14% +$125K 0.02% 167
2023
Q1 		$862K Sell
1,875
-7
-0.4% -$3.33K 0.02% 178
2022
Q4 		$965K Hold
1,882
– – 0.02% 152
2022
Q3 		$855K Sell
1,882
-289
-13% -$138K 0.02% 159
2022
Q2 		$1.05M Buy
2,171
+1,228
+130% +$608K 0.02% 137
2022
Q1 		$463K Sell
943
-329
-26% -$150K 0.01% 203
2021
Q4 		$590K Sell
1,272
-255
-17% -$107K 0.01% 204
2021
Q3 		$569K Hold
1,527
– – 0.01% 211
2021
Q2 		$583K Sell
1,527
-286
-16% -$109K 0.01% 206
2021
Q1 		$651K Buy
1,813
+100
+6% +$32.2K 0.01% 185
2020
Q4 		$550K Sell
1,713
-1,264
-42% -$388K 0.01% 192
2020
Q3 		$800K Buy
2,977
+184
+7% +$49.5K 0.02% 158
2020
Q2 		$735K Sell
2,793
-283
-9% -$75.5K 0.03% 161
2020
Q1 		$698K Sell
3,076
-921
-23% -$251K 0.14% 148
2019
Q4 		$1.21M Buy
3,997
+780
+24% +$215K 0.16% 142
2019
Q3 		$772K Sell
3,217
-150
-4% -$41.1K 0.11% 170
2019
Q2 		$950K Buy
3,367
+753
+29% +$206K 0.14% 157
2019
Q1 		$750K Sell
2,614
-513
-16% -$148K 0.11% 188
2018
Q4 		$821K Sell
3,127
-453
-13% -$125K 0.13% 180
2018
Q3 		$981K Buy
3,580
+350
+11% +$90.9K 0.12% 181
2018
Q2 		$769K Buy
3,230
+100
+3% +$23.2K 0.11% 194
2018
Q1 		$688K Sell
3,130
-240
-7% -$56.4K 0.11% 193
2017
Q4 		$758K Sell
3,370
-240
-7% -$51.1K 0.1% 189
2017
Q3 		$685K Buy
3,610
+1,650
+84% +$314K 0.1% 190
2017
Q2 		$369K Sell
1,960
-730
-27% -$131K 0.06% 249
2017
Q1 		$445K Sell
2,690
-1,300
-33% -$207K 0.07% 218
2016
Q4 		$574K Sell
3,990
-350
-8% -$46.9K 0.1% 188
2016
Q3 		$544K Buy
4,340
+10
+0.2% +$1.29K 0.07% 229
2016
Q2 		$569K Buy
4,330
+610
+16% +$83.5K 0.09% 191
2016
Q1 		$517K Buy
3,720
+500
+16% +$66.8K 0.08% 194
2015
Q4 		$449K Sell
3,220
-900
-22% -$124K 0.07% 206
2015
Q3 		$577K Buy
4,120
+100
+2% +$15K 0.1% 188
2015
Q2 		$660K Buy
4,020
+200
+5% +$32K 0.1% 182
2015
Q1 		$590K Sell
3,820
-2,055
-35% -$293K 0.09% 186
2014
Q4 		$738K Sell
5,875
-50
-0.8% -$6.18K 0.11% 196
2014
Q3 		$709K Buy
5,925
+383
+7% +$43.9K 0.11% 198
2014
Q2 		$596K Buy
5,542
+3,170
+134% +$327K 0.09% 215
2014
Q1 		$236K Sell
2,372
-4,830
-67% -$437K 0.04% 331
2013
Q4 		$665K Sell
7,202
-5,318
-42% -$473K 0.11% 189
2013
Q3 		$1.05M Buy
12,520
+4,036
+48% +$346K 0.19% 131
2013
Q2 		$694K Buy
+8,484
New +$635K 0.13% 176

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Meiji Yasuda Life Insurance's ELV Position: Q2 2024 in Review

Meiji Yasuda Life Insurance sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 3,520 shares — an estimated $1.83M sold.

Meiji Yasuda Life Insurance first reported a position in ELV in Q2 2013 and held it in 44 quarters. The position peaked at $1.83M in Q1 2024. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Meiji Yasuda Life Insurance reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Meiji Yasuda Life Insurance sold 3,520 Elevance Health shares in Q2 2024, an estimated $1.83M.
  • Meiji Yasuda Life Insurance first reported a position in Elevance Health in Q2 2013 and held it in 44 quarters.
  • Meiji Yasuda Life Insurance's Elevance Health position peaked at $1.83M in Q1 2024.
  • 1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Meiji Yasuda Life Insurance's 13F filing for Q2 2024, filed 12 Aug 2024.